Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy.
Eng SE, Basasie B, Lam A, John Semmes O, Troyer DA, Clarke GD, Sunnapwar AG, Leach RJ, Johnson-Pais TL, Sokoll LJ, Chan DW, Tosoian JJ, Siddiqui J, Chinnaiyan AM, Thompson IM Jr, Boutros PC, Liss MA.
Eng SE, et al. Among authors: clarke gd.
Prostate Cancer Prostatic Dis. 2024 Mar;27(1):65-72. doi: 10.1038/s41391-022-00591-w. Epub 2022 Sep 12.
Prostate Cancer Prostatic Dis. 2024.
PMID: 36097168